Breast cancer (BC) is a very aggressive and frequently metastatic tumor in women.
Chemotherapy has proven to be a promising treatment option to combat this type of cancer …

In the advancement of tumor therapy, in addition to the search for new antitumor
compounds, the development of nano-drug delivery systems has opened up new pathways …

Highlights•Discusses biological advantages of co-delivery of multiple agents in cancer
therapy.•Nanovehicles can be used for simultaneous delivery of drug–drug or drug–gene …

Bacterial therapy is emerging for the treatment of cancers though some scientific and clinical
problems have not been addressed. Here, a live drug-loaded carrier, paclitaxel-in-liposome …

Resistance to common chemotherapeutic agents is a frequent phenomenon in late-stage
breast cancers. An ideal system capable of the co-delivery of hydrophobic and hydrophilic …

The aim of this study was to design and optimize risperidone (RIS) mucoadhesive buccal
tablets for systemic delivery as an alternative route. Direct compression method was used for …

Nanocolloids are considered ideal carriers for hydrophobic drugs owing to their core–shell
structure. Lapatinib is a potential anti-cancer agent, but its clinical use is limited because of …

Given the numerous adverse effects of lung cancer treatment, more research on non-toxic
medications is urgently needed. Curcumin (CUR) and berberine (BBR) combat drug …

Introduction: Breast cancer stands the second prominent cause of death among women. For
its efficient treatment, Lapatinib (LAPA) was developed as a selective tyrosine kinase …

Codelivery of chemo-sensitizers with chemotherapeutics using combo nanomedicine is a
promising platform for overcoming chemoresistance in breast cancer. However, tumor …